Does Dr. LOUI ABDELGHANI have financial conflicts of interest?

Dr. LOUI ABDELGHANI (M.D) has received a total of $1,697 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,697 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. LOUI ABDELGHANI?

According to CMS Open Payments data, Dr. LOUI ABDELGHANI received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($285), ACTELION PHARMACEUTICALS US ($221), and ASTRAZENECA PHARMACEUTICALS ($179).

Does Dr. LOUI ABDELGHANI receive research grants or speaking fees?

Dr. LOUI ABDELGHANI has received $1,697 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. LOUI ABDELGHANI

M.DReal-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: STOCKTON, CA 95210

NPI Number: 1912161787

LIFETIME INDUSTRY VALUE

$1,697

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDELGHANI is a verified Internal Medicine, Pulmonary Disease practitioner based in STOCKTON, CA.

Between 2021 and 2024, Dr. ABDELGHANI had an overall industry promotional and research financial footprint of $1,697 as recorded in the federal CMS Open Payments database.

$1,697 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDELGHANI's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $285 (representing 16.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$285

16.8%

ACTELION PHARMACEUTICALS US

Rank 2

$221

13%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$179

10.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.